Combining the diabetes medication metformin and the antihistamine clemastine increased myelin repair in people with RRMS, ...

Join the School of Medicine’s Department of Population and Quantitative Health Sciences to learn about the options available with an MS in clinical research. A webinar will be held Sunday, Dec. 20, at ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...

The CAR T-cell therapy equecabtagene autoleucel, or eque-cel, was shown in trial to improve walking ability for five progressive MS patients.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a ...

Affiliated with the UB Institute for Artificial Intelligence and Data Science, the lab allows Ramanathan and his ...

Please provide your email address to receive an email when new articles are posted on . Less than 1% of current MS-based literature is focused on underrepresented groups. The CHIMES trial specifically ...

The Combined Bachelor’s/Master’s Degree program (CBM) is intended for highly motivated current CWRU undergraduate students who are candidates for any bachelor's ...

The pain, mood changes, brain decline and neurological problems associated with early MS can appear years before diagnosis, ...